Master the upcoming ICD-10 code and IPPS changes! Prepare your team for the upcoming changes taking effect on October 1. Discover the benefits of IPPSPalooza and how it can drive your success. Click here >

Is the False Claims Act Heading to the Supreme Court?

A decision last week by a Federal Appeals Court could impact the False Claims Act.

The Eighth Circuit Court of Appeals, which covers states in the middle part of the country from Minnesota and the Dakotas down to Missouri and Arkansas, concluded that to prevail in a False Claims Act (FCA) case, the relator/government must show that the bills in question would not have been submitted to the government “but for” the kickback. The relator in the case (United States ex rel. Cairns v. D.S. Medical, LLC, 2022 WL 2930946 [8th Cir. July 26, 2022]) asserted that kickbacks paid by a device company to a physician meant that any bill for a service performed by that physician involving the device were false. The plaintiff’s theory, in essence, was “Once there is a kickback, the work of the physician related to the kickback is tainted. The trial court agreed, and the physician lost at trial. But the Eighth circuit reversed, ruling that for the government to prevail in this sort of case, it must prove that “but for” the alleged kickback, the claim in question would not have been submitted.

The case is an interpreting of a sentence from 2010 Amendments to the False Claims Act that says that “A claim that includes items or services resulting from a violation of the Anti-kickback Statute constitutes a false claim.” The case is interpreting the phrase “resulting from.” The Eighth Circuit concluded that the phrase “resulting from” should be interpreted as meaning that if the kickback would not have occurred, the claim would not have been submitted. This interpretation greatly narrows the sorts of kickback cases than can result in false claims. It’s relatively common to have situations where a physician is going to perform a particular procedure and the only question is whether they will use product A or product B.  For example, imagine that a physician has decided that a patient requires a knee replacement. There are a variety of implants available. If “Knees R Us” has paid the physician a kickback, and the physician uses their implant rather than one by a different vendor, the bill to Medicare will be the same. The knee replacement will be paid based on a DRG if done as in inpatient, or under the ASC fee schedule or an APC if done in an ASC or outpatient hospital setting. The Eighth Circuit is saying that with those facts, there is no liability under the FCA. I want to stress that this does not legalize kickbacks. Under these facts, the physician could still be criminally prosecuted. But the court is making an important distinction between criminal cases and false claims act cases, noting that if the government didn’t pay more money than it would have absent the kickback, there should not be liability under the FCA. Given the extreme financial penalties associated with the FCA, such a result makes a lot of sense.

The bottom line is that while there might still be criminal liability for the kickback, at least in the Eighth Circuit, when a kickback results in a physician choosing a particular product that is bundled in the cost of a procedure that they were going to perform anyway, there is no false claim. This question likely to be hotly contested because Third Circuit reached the opposite conclusion in United States ex rel. Greenfield v. MedCo Health Solutions. The Third Circuit covers Pennsylvania, New Jersey, Delaware and the Virgin Islands.  

So, what does this mean? In at least some parts of the country it will be much harder for someone to bring a False Claims Act case in situations where a kickback may have encouraged a physician to choose a drug or device, but there was no over-utilization of services. In addition, this may be a question that goes to the Supreme Court. The Supreme Court chooses what cases it will take, but it often takes significant issues when there is a dispute between the appeals courts.

This is certainly a decision which can have large financial implications, so it is very possible that this issue will someday be addressed by the high court.

Programming Note: Listen to healthcare attorney David Glaser’s Risky Business segment every Monday on Monitor Mondays.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn
Email
Print

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

Mastering the Two-Midnight Rule: Keys to Navigating Short-Stay Admissions with Confidence

The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.

Print Friendly, PDF & Email
September 19, 2023
Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Secondary Diagnosis Coding: A Deep Dive into Guidelines and Best Practices

Explore comprehensive guidelines and best practices for secondary diagnosis coding in our illuminating webcast. Delve into the intricacies of accurately assigning secondary diagnosis codes to ensure precise medical documentation. Learn how to navigate complex scenarios and adhere to coding regulations while enhancing coding proficiency. Our expert-led webcast covers essential insights, including documentation requirements, sequencing strategies, and industry updates. Elevate your coding skills and stay current with the latest coding advancements so you can determine the correct DRG assignment to optimize reimbursement, support medical decision-making, and maintain compliance.

Print Friendly, PDF & Email
September 20, 2023
Principal Diagnosis Coding: Mastering Selection and Sequencing

Principal Diagnosis Coding: Mastering Selection and Sequencing

Enhance your inpatient coding precision and revenue with Principal Diagnosis Coding: Mastering Selection and Sequencing. Join our expert-led webcast to conquer the challenges of principal diagnosis selection and sequencing. We’ll decode the intricacies of ICD-10-CM guidelines, equipping you with a clear grasp of the rules and the official UHDDS principal diagnosis definition. Uncover the crucial role of coding conventions, master the sequencing of related conditions, and confidently tackle cases with equally valid principal diagnoses.

Print Friendly, PDF & Email
September 14, 2023
2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

2024 IPPS Summit: Final Rule Update with Expert Insights and Analysis

Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY24 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.

Print Friendly, PDF & Email
2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

2024 IPPS Summit Day 3: MS-DRG Shifts and NTAPs

This third session in our 2024 IPPS Summit will feature a review of FY24 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from two acclaimed subject matter experts

Print Friendly, PDF & Email
August 17, 2023

Trending News